SIGHT.PA Gross Margin

The Gross Margin of Gensight Biologics SA (SIGHT.PA) is 188.37%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SIGHT.PA Gross Margin - Historical Value

Date	Value
2024-12-31	188.37%

SIGHT.PA Gross Margin - Peers Comparison

Ticker	Name	Value
BINV.ST	BioInvent International AB	42.37%
CANTA.ST	Cantargia AB	7775.20%
HPHA.DE	Heidelberg Pharma AG	74.01%
OSE.PA	OSE Immunotherapeutics SA	100.00%
TILS.L	Tiziana Life Sciences PLC	63.16%
XBRANE.ST	Xbrane Biopharma AB	90.83%
NANO.PA	Nanobiotix SA	100.00%
ALQGC.PA	Quantum Genomics SA	-14205.07%
IVACC.ST	Intervacc AB	-29.92%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
ALSEN.PA	Sensorion SA	7775.20%
BGBIO.OL	Bergenbio ASA	100.00%
IVA.PA	Inventiva SA	146.31%
MAB.WA	Mabion SA	75.54%
NANOV.OL	Nordic Nanovector ASA	7775.20%
ORY.MC	Oryzon Genomics SA	-4700.00%
SANION.ST	Saniona AB	85.03%
ALBPS.PA	Biophytis SA	7775.20%
DMYD B.ST	Diamyd Medical AB	-10161.54%
VVY.AS	Vivoryon Therapeutics NV	85.42%
BVXP.L	Bioventix PLC	93.20%
POXEL.PA	Poxel SA	0.05%
SCLP.L	Scancell Holdings PLC	90.13%
SNG.L	Synairgen PLC	68.75%
ABVX.PA	Abivax SA	-19700.00%
FARN.L	Faron Pharmaceuticals Oy	95.19%
ORPHA.CO	Orphazyme A/S	7775.20%